🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: AS01

Found 23 matching trials

Impact of Vaccines on Antimicrobial Microbial Resistance

N/A

Vaccination is a potentially critical component of efforts to arrest develo...

Status

Completed

Location

Malawi Liverpool Wellcome Programme

Start Date

2021-03-15

Trial ID

NCT06450379

A Safety and Efficacy Study of Concomitant Administration of ChAd63/MVA ME-TRAP + RTS,S

PHASE1

The purpose of this study is to assess two types of new malaria vaccines in...

Status

Completed

Location

NIHR WTCRF, University Hospital Southampton NHS Foundation Trust

Start Date

2015-01

Trial ID

NCT02252640

Treatments Being Tested

RTS,S/AS01B (50mcg of RTS,S and standard adult dose of AS01)RTS,S/AS01B (10mcg of RTS,S and one fifth of the standard dose of AS01)ChAd63 ME-TRAP (5 x 10^10 vp)MVA ME-TRAP (2 x 10^8 pfu)

A Study to Evaluate the Reactogenicity, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Supra-seasonal Universal Influenza Vaccines - Inactivated (SUIVs) (GSK3816302A) in Healthy Adults Aged 18 to 39 Years

PHASE1

The purpose of this study is to assess the reactogenicity, safety and immun...

Status

Completed

Location

GSK Investigational Site

Start Date

2017-09-08

Trial ID

NCT03275389

Treatments Being Tested

D-SUIV cH8/1N1+AS03 D-SUIV cH5/1N1+AS03 D-SUIV cH11/1N1+AS03 D-SUIV cH8/1N1+AS01 D-SUIV cH5/1N1+AS01 D-SUIV cH11/1N1+AS01 D-SUIV cH8/1N1 D-SUIV cH5/1N1 D-SUIV cH11/1N1 Placebo Fluarix Quadrivalent

A Study to Evaluate the Efficacy, Immunogenicity and Safety in a Sporozoite Challenge Model of a Fractional Booster Dose of GSK Biologicals' Candidate Malaria Vaccine Administered to Previously Vaccinated Healthy Malaria-naïve Adults

PHASE2

MALARIA-092 (NCT03162614) study was designed to evaluate the efficacy, immu...

Status

Completed

Location

GSK Investigational Site

Start Date

2019-02-05

Trial ID

NCT03824236

Treatments Being Tested

RTS,S/AS01E (SB257049)

Efficacy, Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Evaluating Different Dose Schedules in a Sporozoite Challenge Model in Healthy Malaria-naïve Adults

PHASE2

This study is designed to evaluate efficacy, immunogenicity and safety of v...

Status

Completed

Location

GSK Investigational Site

Start Date

2017-05-24

Trial ID

NCT03162614

Treatments Being Tested

RTS,S/AS01E RTS,S/AS01B Sporozoite-infected mosquitoes challenge.

Pfs230D1M-EPA/AS01 Vaccine, a Transmission Blocking Vaccine Against Plasmodium Falciparum, in an Age De-Escalation Trial of Children and a Family Compound Trial in Mali

PHASE2

Background: Malaria affects many people in Mali and other parts of Africa....

Status

Completed

Location

Mrtc/Usttb

Start Date

2019-04-24

Trial ID

NCT03917654

Treatments Being Tested

Pfs230D1M-EPA/AS01 HAVRIX TYPHIM Vi (Salmonella typhi vaccine)Menactra AVAXIM

RTSS Vaccine and PBO Net Impact on Malaria Infection and Transmission in Malawi

N/A

The overall goal of this study is to assess the impact of RTS,S (malaria) v...

Status

Completed

Location

University of Malawi College of Medicine

Start Date

2020-02-04

Trial ID

NCT04327440

Treatments Being Tested

RTS,S/AS01 malaria vaccine PBO bed nets

The Impact RTS,S/AS01 Vaccine in School Aged Children RTS,S/AS01 Malaria Vaccine in School Aged Children

PHASE4

Across sub-Saharan Africa, school-age children bear an under-appreciated bu...

Status

Unknown

Location

Multiple Locations

Start Date

2024-06-01

Trial ID

NCT06424002

Treatments Being Tested

Mosquirixs artemether-lumefantrine

Strengthening the Evidence for Policy on the RTS,S/AS01 Malaria Vaccine

N/A

The ongoing Malaria Vaccine Pilot Evaluation (MVPE) is being conducted in G...

Status

Recruiting

Location

Kintampo Health Research Centre

Start Date

2021-10-18

Trial ID

NCT05041556

Treatments Being Tested

Case-control study of clinical outcomes Case-control study of mortality outcome

A Safety and Efficacy Study of ChAd63/MVA METRAP + RTS,S

PHASE1

This is a clinical trial in which healthy volunteers will be administered e...

Status

Completed

Location

Wellcome Trust CRF, Southampton General Hospital, University of Southampton

Start Date

2013-09

Trial ID

NCT01883609

Treatments Being Tested

RTS,S/AS01B ChAd63 ME-TRAP MVA ME-TRAP

Previous Next